MedTrace Logo

Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease

NCT06615453 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-01-26

No results posted yet for this study

Summary

This study will examine how a standard Tixel treatment versus a sham treatment for eye wrinkles affects the symptoms and signs of Dry Eye Disease.

Conditions

  • Dry Eye Disease (DED)

Interventions

DEVICE

Thermo-mechanical action based peri-orbital fractional skin treatment

Participants will receive three Tixel® treatments at 2-weeks intervals

DEVICE

Sham treatment

Participants will receive three sham treatments at 2-weeks intervals

Sponsors & Collaborators

  • Aston University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-17
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06615453 on ClinicalTrials.gov